Cargando…
Botulinum toxin in the management of acquired motor fusion deficiency
Acquired disruption of motor fusion is a rare condition characterized by intractable diplopia. Management of these patients is extremely difficult. Prisms in any combination or even surgery may not help relieve their symptoms. We describe a longstanding case of acquired motor fusion disruption which...
Autores principales: | Murthy, Ramesh, Kesarwani, Siddharth |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812768/ https://www.ncbi.nlm.nih.gov/pubmed/19861751 http://dx.doi.org/10.4103/0301-4738.57162 |
Ejemplares similares
-
Botulinum toxin in the management of acquired motor fusion deficiency: The missing links
por: Pandey, Pramod Kumar, et al.
Publicado: (2010) -
Botulinum toxin treatment for hypersalivation in anti‐NMDA receptor encephalitis
por: Jun, Jin‐Sun, et al.
Publicado: (2017) -
Botulinum toxin‐a treatment reduces human mechanical pain sensitivity and mechanotransduction
por: Paterson, Kathryn, et al.
Publicado: (2014) -
Altered cortical activation from the hand after facial botulinum toxin treatment
por: Haenzi, Sara, et al.
Publicado: (2014) -
Comparison of different antibiotic protocols for asymptomatic bacteriuria in patients with neurogenic bladder treated with botulinum toxin A
por: Paradella, Ana Claudia, et al.
Publicado: (2016)